Hamzeh Karimkhanloo
Melbourne, VIC 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism.
Journal: Cell reports
Published: February 29, 2024
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies.
Journal: Scientific reports
Published: November 25, 2022
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control.
Journal: Nature communications
Published: March 29, 2021
Circulating cathepsin S improves glycaemic control in mice.
Journal: The Journal of endocrinology
Published: November 19, 2020
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma.
Journal: Molecular biology reports
Published: April 11, 2020
Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 06, 2017
WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.
Journal: Applied biochemistry and biotechnology
Published: February 04, 2016
Carbon nanotubes: properties, synthesis, purification, and medical applications.
Journal: Nanoscale research letters
Published: April 29, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026